New York City, NY -- (SBWIRE) -- 10/04/2013 -- StockMarketIntel.com issues a special report on the following stocks: NanoTech Entertainment, Inc.(OTCMKTS:NTEK) , Mast Therapeutics Inc(NYSEMKT:MSTX) , VIVUS, Inc.(NASDAQ:VVUS) , Sirius XM Radio Inc(NASDAQ:SIRI)
NanoTech Entertainment, Inc.(OTCMKTS:NTEK) recently gained 13.10%, while trading on 16.16M shares at the price of $0.12. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.0005 and was moved to its maximum level of $0.1395.The stock changed hands in a range of $0.109 to $0.126, bringing its market capitalization at about $59.99 million. NanoTech Entertainment, Inc. operates as a technology company with focus on entertainment industry worldwide. The company virtual manufactures and develops technology and games, and then licenses to coin-op arcade, casino gaming, and consumer gaming markets.
For How Long NTEK will fight for Profitability? Read This Trend Analysis report
Mast Therapeutics Inc(NYSEMKT:MSTX) added 8.50% recently, while trading on 11.67M shares at the price of $0.49. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.40 and was moved to its maximum level of $0.815.The stock changed hands in a range of $0.4855 to $0.539, bringing its market capitalization at about $50.33 million. Mast Therapeutics, Inc., a biopharmaceutical company, focuses on developing therapies for serious or life-threatening diseases. Its lead product candidate includes MST-188, a product candidate that has hemorheologic, cytoprotective, and anti-inflammatory properties, which is in phase 3 study for the treatment of sickle cell disease in patients.
For How Long MSTX Gloss will Attract Investors? Find out via this report
VIVUS, Inc.(NASDAQ:VVUS) recently gained +8.44% and was moving within a range of $10.7601-$11.64, its current trading price is $11.05. The stock is moving up till now with a total volume of 11.53M shares, versus an average volume of 2.76M shares. The share price hit its 52-week low of $9.11 and $23.59 was the best price. VIVUS, Inc. is a biopharmaceutical company. It commercializes and develops therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. Its drug, Qsymia (phentermine and topiramate extended-release) was approved by the the United States Food and Drug Administration (FDA) for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 or greater (obese).
Why Should Investors Buy VVUS After the Recent Fall? Just Go Here and Find Out
Sirius XM Radio Inc(NASDAQ:SIRI) declined -1.51% in its current trading activity, bringing its market capitalization around $24.34 billion. The total number of shares that changed hands during the current session up till now was 49.34M shares, as compared to average trading volume of 36.15M shares. The share price after opening at $3.98 made a high of $3.98 and hovered above $3.91, while its recent trading price was $3.92. Sirius XM Radio Inc. provides satellite radio services in the United States and Canada. The company broadcasts music, sports, entertainment, comedy, talk, news, traffic, and weather channels on subscription fee basis through two satellite radio systems.
Why Should Investors Buy SIRI After the Recent Fall? Just Go Here and Find Out
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)